I also have a lot of patients who have not lost a significant amount of weight on GLP1 agonists or tirzepatide, so genetics also play a role (and definitely lifestyle which is the most important issue we need to address- talk to patients to make changes for the entire family).the patients who have not lost a significant amount of weight may actually be a good cohort to look at for CV benefits- they usually have good glycemic control on these drugs and that of course contributes to decreased inflammatory markers etc so it will still be difficult to pin CV benefits of GLP1 agonists independent of weight loss and glycemic control
J.St-JacquesB.ShenL.MohlerJ.McMahonJ
At NOCO Healthcare, one of the most common questions we hear is, whats the difference between Tirzepatide vs Semaglutide? If youre exploring your options for medical weight loss, this guide will help you understand how these medications work, their differences, and how to determine which treatment may fit your goals
Individuals with inborn errors of metabolism that affect homocysteine metabolism may require methionine-restricted diets and supplemental betaine and amino acids.21 CVD The American Heart Association recognizes hyperhomocysteinemia as an independent risk factor for CVD, atherosclerosis, stroke, thromboembolism, and myocardial infarction.7 Some research has demonstrated correlations between plasma homocysteine levels and the severity of atherosclerotic disease, as well as associations between hyperhomocysteinemia and increased risk of cardiovascular death
Two expandable front mesh pockets hold 20oz flasks within reach so you never break stride
